Nintedanib
NDC 60505-4818, Nintedanib, capsule, from Apotex Corp..
- Product NDC
- 60505-4818
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219227
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4818 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NINTEDANIB ESYLATE100 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-4818-6 | 60505481806 | 1 BOTTLE in 1 CARTON (60505-4818-6) / 60 CAPSULE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b72b26c3-7731-80c0-734b-a5f53a1d89ae
Use it
Look up 60505-4818 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4818 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-4818. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.